Grade peptides FAQ

Use it only if the research timeline is short and the 2% impurity is characterized on the CoA. If the contaminants are residual solvents (acetonitrile, TFA) or salts, the peptide remains usable for most behavioral research. If the contaminants are deletion sequences (truncated peptides missing one or more amino acids) or bacterial endotoxins, reject the batch. Deletion sequences compete for receptor binding without activating downstream signaling, effectively reducing your active dose, and endotoxins introduce inflammatory variables that confound mood measurements. For publication-quality research, 98% purity is the defendable standard.

Reconstitute a small aliquot separately and observe dissolution time. Authentic SS-31 dissolves completely within 60 seconds in bacteriostatic water with gentle swirling, producing a clear or faintly opalescent solution. Slow dissolution, visible particulates, or persistent cloudiness indicates impurities, incomplete lyophilization, or degraded peptide. Do not use the material for research—poor solubility correlates with structural problems that affect mitochondrial membrane interaction. Contact the supplier immediately and request a replacement vial with COA documentation. If the supplier resists or offers excuses, the batch is likely substandard and the source unreliable.

Request batch-specific COAs and compare HPLC chromatograms. Variability in GH pulse amplitude or timing between batches suggests inconsistent purity or sequence errors in one of the batches. Even 2–3% purity differences can shift receptor binding kinetics enough to alter downstream signaling. If your supplier cannot provide chromatogram overlays showing identical retention times and peak shapes, switch suppliers. Batch-to-batch consistency is the foundation of reproducible research. Real Peptides maintains <1.5% relative standard deviation in purity across sequential batches, documented in our quality control records.

Lyophilized SS-31 tolerates short-term ambient temperature exposure (24–48 hours at ≤25°C) without significant degradation, but prolonged storage above recommended conditions (−20°C for long-term, 2–8°C for short-term) accelerates oxidation of methionine-like residues and peptide bond hydrolysis. If the vial arrived warm or was left at room temperature for more than 72 hours, request a replacement. Once reconstituted, SS-31 must be stored at 2–8°C and used within 28 days—any temperature excursion above 8°C after reconstitution denatures the peptide irreversibly. Temperature abuse is undetectable visually but compromises experimental consistency. For mitochondrial studies, structural integrity is non-negotiable—when in doubt, discard and reorder.

Source both peptides from the same supplier to control for synthesis methodology and purity standards—comparing compounds from different vendors introduces uncontrolled variables in peptide quality that confound pharmacological comparisons. Administer equimolar doses (not equal mass doses) to account for the molecular weight difference introduced by the Amidate modification. Expect Semax Amidate to produce longer-duration effects with lower peak magnitude compared to standard Semax at equivalent doses—the extended half-life flattens the concentration-time curve. Measure outcomes at matched timepoints relative to each compound's pharmacokinetic profile: 30–60 minutes post-dose for Semax, 90–120 minutes for Semax Amidate.

Oxytocin's mood effects are significantly weaker in isolation compared to social contexts. A 2023 study in Psychoneuroendocrinology found that oxytocin reduced self-reported anxiety by 28% during social interaction tasks but only 9% during solo cognitive tasks with identical stress levels. If your protocol isolates subjects, expect smaller effect sizes and plan sample size accordingly. Peripheral biomarkers (cortisol, heart rate variability) may show measurable changes even when subjective mood ratings do not.

Discard the vial immediately and do not inject. Visible particles indicate peptide aggregation, which occurs when improper reconstitution technique, pH shift, or temperature fluctuation causes the peptide to denature and clump. Aggregated peptides lose receptor binding affinity and can trigger immune responses in animal models that confound recovery data. Proper reconstitution requires injecting bacteriostatic water slowly down the vial wall. Never directly onto the lyophilized powder. And allowing dissolution to occur passively without shaking or vortexing. If aggregation occurs despite correct technique, the lyophilized peptide likely experienced temperature abuse during storage or shipping.

Verify the laboratory name and accreditation independently. Legitimate third-party analytical labs (e.g., those accredited under ISO/IEC 17025) list contact details, accreditation numbers, and testing methodologies on COAs. If the document names a laboratory but provides no phone number, website, or accreditation reference, it may be fabricated. Search the lab name online—authentic testing facilities have public websites and client portals. If you cannot verify the laboratory's existence or accreditation, treat the COA as unreliable. Request a new analysis from a lab you verify independently, or source from a supplier with transparent third-party relationships like Real Peptides, where every SS-31 Elamipretide batch includes verifiable external testing.

Discard the vial immediately and do not administer. Cloudiness indicates peptide aggregation or precipitation, meaning the molecular structure has been compromised and the compound is no longer in its active monomeric form. Aggregated peptides can trigger immune responses in vivo and produce inconsistent pharmacokinetics that invalidate dose-response data. Reconstitute a fresh vial using slower bacteriostatic water addition and gentler swirling—if cloudiness persists across multiple vials from the same batch, contact the supplier for batch replacement as this indicates a synthesis or lyophilization defect.

This pattern suggests receptor desensitization, not peptide degradation. Melanocortin receptors MC4 and MC5 undergo downregulation with chronic agonist exposure, reducing response magnitude over 7–10 days of daily administration. The best Semax Amidate for focus protocols incorporate 48–72 hour washout periods between dosing cycles to allow receptor resensitization. Alternatively, reduce administration frequency to every other day or implement a 5-days-on, 2-days-off schedule. Increasing dose to overcome tolerance introduces nonlinear kinetics and potential off-target effects at MC1 and MC3 receptors—cycling is pharmacologically preferable to dose escalation.

Verify three variables before concluding the peptide is inactive: administration technique, baseline cortisol levels, and OXTR genotype. Improper nasal spray technique (spraying into the throat instead of upper nasal passages) reduces olfactory nerve uptake by 60%. Subjects with chronically elevated baseline cortisol (above 15 µg/dL) demonstrate blunted oxytocin receptor sensitivity. OXTR rs53576 AA genotype carriers show 35–50% weaker anxiolytic responses compared to GG carriers. If all three check out and the peptide was stored correctly, consider dose escalation to 48–60 IU or switching to a different synthesis batch with fresh CoA verification.

GRHP-6 can be safely mixed with GHRH analogs like CJC 1295 NO DAC or Ipamorelin in the same syringe immediately before injection. This is common in synergistic GH release protocols. Do not store mixed peptides for more than 10–15 minutes before administration, as co-solution stability is not guaranteed beyond short timeframes. Never mix GHRP-6 with insulin, heparin, or any peptide in a different buffer system (e.g., phosphate-buffered vs acetate-buffered), as pH incompatibility causes immediate precipitation.

Discard it and prepare a fresh solution. Even 8–12 hours at room temperature (20–25°C) allows partial oxidation of the disulfide bond between cysteine residues, reducing receptor binding affinity by 30–50%. The peptide may appear visually identical, but the molecular structure has degraded. Oxytocin lacks a visual indicator of potency loss, which is why strict temperature control is non-negotiable. When in doubt, reconstitute fresh rather than risk compromised data.

Dissolve a small test quantity (0.5–1 mg) in sterile water and visually inspect for clarity. Functional SS-31 should dissolve completely within 2–3 minutes of gentle agitation, forming a clear to slightly opalescent solution with no visible particulates. If the solution remains cloudy, contains floating aggregates, or shows color (yellow, brown, or pink tints), the peptide has likely undergone oxidative degradation or moisture absorption during storage. Contact your supplier immediately with photographic documentation. Reputable suppliers replace compromised batches at no cost. Do not proceed with experiments using visibly degraded peptide; oxidized SS-31 produces inconsistent results and introduces uncontrolled variables into mitochondrial targeting assays.

Request it before purchase. If they can't provide MS data, you cannot confirm the peptide sequence is correct. HPLC tells you the sample is pure but not what it's pure of. Deletion sequences (peptides missing one or more amino acids) often co-elute with the target peptide or elute as nearby peaks that don't significantly lower HPLC purity percentage, but they are structurally distinct molecules with altered or absent bioactivity. Mass spectrometry is the only analytical method that definitively confirms molecular weight and therefore amino acid sequence. A peptide sold as PE-22-28 without MS verification could be a closely related analog, a deletion sequence, or even an entirely different peptide that happens to have similar HPLC retention time. Our PE 22 28 includes MS confirmation within ±1 Da of expected mass in every batch-specific CoA.

Do not proceed with that supplier. Batch-specific MS data is the only definitive proof that the peptide sequence matches SS-31's structure. Without it, you have no verification that dimethyltyrosine was incorporated or that the four-residue sequence is correct. Generic certificates referencing "representative batches" or historical data from different synthesis runs are insufficient for research-grade work. The best SS-31 supplier includes MS data as standard documentation, not a premium service. If your current supplier cannot provide it, switch to a vendor who can. The cost of using mislabeled or degraded peptide far exceeds the cost of sourcing from a verified supplier.

Verify the supplier provides synthesis method disclosure, analytical method validation, and stability data under ICH guidelines. Regulatory submissions and GLP-compliant studies require complete characterization of all research materials, including peptide source, synthesis and purification methods, purity determination methods, impurity profiles, and stability under stated storage conditions. Real Peptides maintains documentation packages for all peptides that include synthesis protocol (SPPS with specified coupling reagents and protecting groups), purification method (preparative HPLC with gradient details), analytical methods (HPLC method with column type, mobile phase, gradient, and detection wavelength; MS method with ionization mode and mass range), and accelerated stability data showing degradation rates at −20°C, 4°C, and 25°C over 12 months. This level of documentation is uncommon among research peptide suppliers but is mandatory for regulatory-grade work.

Check peptide content by amino acid analysis, not just HPLC purity. HPLC measures relative abundance of UV-absorbing species but doesn't distinguish peptide mass from non-peptide mass like trifluoroacetic acid (TFA) counterions or residual moisture. A peptide with 98% HPLC purity may contain only 85% actual peptide if the remaining 13% is TFA salts carried over from purification. TFA doesn't absorb at 220nm so it doesn't appear in HPLC chromatograms, but it does contribute to vial weight. If you weigh 10mg and assume it's 98% peptide, you may actually have only 8.5mg active compound. This shortfall directly reduces assay performance in dose-response experiments or receptor binding studies where precise molar concentrations are required. Real Peptides reports both HPLC purity and peptide content by AAA so you know exactly how much bioactive peptide you're reconstituting.

Order SS-31 in small vials (1–5 mg) matched to your monthly usage rate rather than one large vial for the entire study. Reconstitute only what you will use within 7–10 days, keeping the remaining lyophilized powder at −20°C until needed. This approach eliminates concentration drift caused by degradation of bulk reconstituted stock and ensures each dosing window uses freshly prepared peptide at verified purity. For multi-month studies, many researchers also request peptides from the same production batch for all timepoints. This minimizes inter-batch variability that could confound longitudinal data.

Yes. In vivo applications require endotoxin testing in addition to standard purity analysis, as even trace lipopolysaccharide (LPS) contamination from bacterial sources can trigger inflammatory responses that confound experimental outcomes. Request a certificate of analysis confirming endotoxin levels below 1 EU/mg (endotoxin units per milligram), measured by LAL (Limulus Amebocyte Lysate) assay. Most peptide suppliers do not test for endotoxin unless specifically requested; researchers conducting animal studies should verify this before ordering. Real Peptides provides endotoxin testing on request for all peptides intended for in vivo work. Ensuring your mitochondrial research is not confounded by immune activation artifacts.